Sort
261,768 grants matching “gene therapy”
Stanford Cancer Institute
$3,334,464Steven E Artandi · Stanford University · P30 · FY2020 · CA
Stanford Cancer Institute
$3,334,365Steven E Artandi · Stanford University · P30 · FY2021 · CA
Therapeutic Index of Acute Lymphoblastic Leukemia
$3,333,857Stephen E Sallan · Dana-Farber Cancer Inst · P01 · FY2009 · CA
HCMR Novel Markers of Prognosis in Hypertrophic Cardiomyopathy
$3,332,510Christopher M Kramer · University Of Virginia · U01 · FY2014 · HL
Studies of Populations Exposed to Therapeutic Medical Radiation and Other Agents
$3,331,177Lindsay Morton · Division Of Cancer Epidemiology And Genetics · ZIA · FY2016 · CA
Transcriptional Functions of Nuclear Receptors in Cancer Cells
$3,327,430Trevor K Archer · National Institute Of Environmental Health Sciences · ZIA · FY2013 · ES
Humanin is an AD resilience factor through its interaction with APOE4
$3,327,055Pinchas Cohen · University Of Southern California · RF1 · FY2018 · AG
TGF-beta Regulation of Mucosal and Systemic T Cell Immunity and Tolerance
$3,326,128Wanjun Chen · National Institute Of Dental & Craniofacial Research · ZIA · FY2019 · DE
Stanford Cancer Institute
$3,324,271Steven E Artandi · Stanford University · P30 · FY2019 · CA
IGERT- Nanomedical Science and Technology
$3,323,891Srinivas Sridhar · Northeastern University · · FY2005 · EDU
Framingham Project/Levy
$3,323,367Daniel Levy · National Heart, Lung, And Blood Institute · ZIA · FY2021 · HL
Structural Biology of Genome Maintenance and DNA repair
$3,320,685Scott Williams · National Institute Of Environmental Health Sciences · ZIA · FY2024 · ES
The UCSC Genome Browser
$3,319,193Maximilian Haeussler · University Of California Santa Cruz · U24 · FY2024 · HG
The UCSC Genome Browser
$3,319,192Maximilian Haeussler · University Of California Santa Cruz · U24 · FY2025 · HG
Joint Center for Mendelian Genomics
$3,317,585Daniel G Macarthur · Broad Institute, Inc. · UM1 · FY2018 · HG
NATIENS: A Phase III Randomized Double Blinded Study to Determine the Mechanisms and Optimal Management of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis
$3,316,841Elizabeth Phillips · Vanderbilt University Medical Center · U01 · FY2022 · AI
Microbial Determinants of Excessive Inflammation and Severe Lyme Disease
$3,315,179Klemen Strle · Tufts University Boston · R01 · FY2025 · AI
Joint Center for Mendelian Genomics
$3,314,598Daniel G Macarthur · Broad Institute, Inc. · UM1 · FY2017 · HG
AAV-mediated editing to treat human autosomal dominant hearing loss DFNA41 and DFNA2
$3,314,560Zheng-Yi Chen · Massachusetts Eye And Ear Infirmary · U01 · FY2024 · TR
Characterization of the Pathogenesis of Lymphangioleiomyomatosis (LAM)
$3,314,109Joel Moss · National Heart, Lung, And Blood Institute · ZIA · FY2013 · HL
Seven Transmembrane-spanning Receptors: Structure and Function
$3,313,220Marvin Gershengorn · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2021 · DK
Neurobiological Predictors of Huntington's Disease
$3,313,194Jane S Paulsen · University Of Iowa · R01 · FY2006 · NS
Targeting Inflammation and Alloimmunity in Lung Transplant Recipients With Clazakizumab
$3,310,755Joren C Madsen · Massachusetts General Hospital · U01 · FY2025 · AI
Neuropsychiatric Genome-Scale and RDOC Individualized Domains (N-GRID)
$3,310,433Isaac S. Kohane · Harvard Medical School · P50 · FY2016 · MH
Role of Retrotransposon Activity in Neurodegeneration and Alzheimer's Disease
$3,310,151John M. Sedivy · Brown University · P01 · FY2022 · AG